BPCE
BIIB icon

Bank Pictet & Cie (Europe)’s Biogen BIIB Stock Holding History

Bank Pictet & Cie (Europe)’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$670K Buy
3,103
+223
+8% +$42.7K 0.01% 152
2026
Q1 		$528K Sell
2,880
-89
-3% -$16.4K 0.01% 158
2025
Q4 		$523K Buy
2,969
+103
+4% +$16.8K 0.01% 155
2025
Q3 		$401K Buy
2,866
+40
+1% +$5.41K 0.01% 165
2025
Q2 		$355K Buy
2,826
+1,212
+75% +$151K 0.01% 169
2025
Q1 		$221K Buy
+1,614
New +$231K 0.01% 171
2024
Q2 		– Sell
-2,557
Closed -$551K – 159
2024
Q1 		$551K Buy
2,557
+161
+7% +$37.7K 0.01% 128
2023
Q4 		$620K Hold
2,396
– – 0.02% 166
2023
Q3 		$616K Sell
2,396
-910
-28% -$243K 0.02% 159
2023
Q2 		$942K Sell
3,306
-290
-8% -$86.3K 0.03% 146
2023
Q1 		$1,000K Sell
3,596
-264
-7% -$73K 0.04% 106
2022
Q4 		$1.07M Buy
3,860
+1,321
+52% +$373K 0.05% 100
2022
Q3 		$678K Buy
2,539
+23
+0.9% +$4.88K 0.03% 114
2022
Q2 		$513K Hold
2,516
– – 0.02% 114
2022
Q1 		$530K Sell
2,516
-3,628
-59% -$789K 0.02% 120
2021
Q4 		$1.47M Buy
6,144
+2,330
+61% +$599K 0.05% 97
2021
Q3 		$1.08M Buy
3,814
+1,545
+68% +$506K 0.04% 104
2021
Q2 		$786K Sell
2,269
-220
-9% -$66.6K 0.03% 112
2021
Q1 		$696K Sell
2,489
-1,684
-40% -$454K 0.03% 111
2020
Q4 		$1.02M Buy
+4,173
New +$1.08M 0.05% 94
2020
Q2 		– Sell
-1,095
Closed -$346K – 130
2020
Q1 		$346K Sell
1,095
-464
-30% -$141K 0.03% 105
2019
Q4 		$463K Sell
1,559
-322
-17% -$89.3K 0.07% 107
2019
Q3 		$438K Hold
1,881
– – 0.07% 111
2019
Q2 		$440K Hold
1,881
– – 0.08% 110
2019
Q1 		$445K Buy
1,881
+436
+30% +$137K 0.08% 101
2018
Q4 		$435K Sell
1,445
-415
-22% -$132K 0.09% 87
2018
Q3 		$657K Buy
1,860
+114
+7% +$39.3K 0.09% 99
2018
Q2 		$507K Buy
1,746
+55
+3% +$15.5K 0.08% 114
2018
Q1 		$463K Buy
1,691
+257
+18% +$79.8K 0.08% 118
2017
Q4 		$457K Sell
1,434
-1,795
-56% -$576K 0.06% 133
2017
Q3 		$1.01M Hold
3,229
– – 0.15% 96
2017
Q2 		$876K Buy
3,229
+730
+29% +$193K 0.12% 120
2017
Q1 		$683K Buy
2,499
+436
+21% +$123K 0.1% 121
2016
Q4 		$585K Buy
2,063
+91
+5% +$27K 0.1% 116
2016
Q3 		$617K Sell
1,972
-202
-9% -$59.8K 0.11% 109
2016
Q2 		$526K Sell
2,174
-200
-8% -$52.7K 0.11% 108
2016
Q1 		$618K Buy
2,374
+181
+8% +$47.8K 0.12% 98
2015
Q4 		$672K Hold
2,193
– – 0.13% 89
2015
Q3 		$640K Buy
2,193
+203
+10% +$67K 0.15% 96
2015
Q2 		$804K Hold
1,990
– – 0.8% 31
2015
Q1 		$840K Buy
1,990
+90
+5% +$35.5K 0.2% 82
2014
Q4 		$645K Sell
1,900
-290
-13% -$93.8K 0.16% 87
2014
Q3 		$724K Sell
2,190
-140
-6% -$46.2K 0.2% 73
2014
Q2 		$735K Buy
2,330
+180
+8% +$54.2K 0.23% 68
2014
Q1 		$658K Buy
2,150
+200
+10% +$63.5K 0.23% 64
2013
Q4 		$546K Buy
+1,950
New +$504K 0.21% 72

Other funds holding BIIB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Bank Pictet & Cie (Europe)'s BIIB Position: Q2 2026 in Review

Bank Pictet & Cie (Europe) increased its Biogen (BIIB) stake by 7.7% in Q2 2026, buying an estimated $42.7K and bringing the position to 3,103 shares worth $670K. The position accounts for 0.01% of the portfolio, ranked #152.

Bank Pictet & Cie (Europe) first reported a position in BIIB in Q4 2013 and has held it in 46 quarters since. The position peaked at $1.47M in Q4 2021. 569 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • Bank Pictet & Cie (Europe) held 3,103 shares of Biogen worth $670K as of Q2 2026.
  • Bank Pictet & Cie (Europe) bought 223 Biogen shares in Q2 2026, an estimated $42.7K.
  • Biogen made up 0.01% of Bank Pictet & Cie (Europe)'s portfolio in Q2 2026, its #152 holding.
  • Bank Pictet & Cie (Europe) first reported a position in Biogen in Q4 2013 and has held it in 46 quarters since.
  • Bank Pictet & Cie (Europe)'s Biogen position peaked at $1.47M in Q4 2021.
  • 569 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Bank Pictet & Cie (Europe)'s 13F filing for Q2 2026, filed 24 Jul 2026.